The Food and Drug Administration has flagged a potentially high-risk issue with breathing equipment used on newborns, warning that tubing can loosen or disconnect from the nasal cannula, interrupting the pressure support that keeps a baby's airway open.
The agency issued an early alert covering nine lot-specific products in the CooperSurgical INCA Infant and Neonatal Nasal CPAP Complete Set and Replacement Set lines. The instruction to facilities is direct: do not use the affected product; identify it; stop its use and distribution; and return it to the company.
CooperSurgical notified affected customers by letter on August 11. The FDA published its alert on August 24 and said it is still reviewing the issue. As of the date of the company's letter, CooperSurgical had reported no serious injuries or deaths connected to the problem.
The Specific Failure Described in the Alert
The INCA assembly delivers continuous positive airway pressure to newborns and infants who need help breathing. A clear, soft nasal cannula sits on the nose, connected to two shapeable tubes that hold it in place to limit movement and prevent nasal trauma, along with built-in tubing adapters, an in-line pressure adapter, a knit cap with fixation straps, and a chin strap.
According to the company's account in the alert, units from specific lots may show a loose connection between the flexible tubing and the nasal cannula, either during assembly or while in use. If that looseness goes undetected during assembly or placement, the tubing may leak at the connection or come off entirely.
The consequence is loss of CPAP pressure. That reduces treatment effectiveness and can lead to decreased oxygenation until the connection is restored.
CooperSurgical's letter stated that if a loose connection is noticed during use, staff should replace the tubing with other tubing or another CPAP device, stop further use and distribution, segregate affected stock, notify personnel who use the devices, and contact any facility to which the product was forwarded.
Nine part numbers are involved, each tied to specific lot codes. The affected items are the INCA Infant Nasal CPAP Complete Set in part numbers 44-2707, 44-2709, 44-2710, 44-2712 and 44-2715, and the INCA Neonatal Nasal CPAP Replacement Set in part numbers 44-0707, 44-0709, 44-0712 and 44-0715. The alert lists the corresponding lot codes and device identifiers.
Hospitals Are the Audience, Parents Are the Stakeholders
This is a professional-use product. It is not sold to consumers, and there is nothing in a household to check.
That distinction shapes what a parent can usefully do. Families with an infant currently on nasal CPAP in a neonatal intensive care unit are not being asked to act, and should not try to inspect or adjust equipment themselves. Identifying affected lots is the responsibility of the hospital's materials management and biomedical engineering staff, who receive these notices directly.
What a parent can reasonably do is ask. A charge nurse or neonatologist can confirm whether a unit uses CooperSurgical INCA sets and whether the facility has checked its inventory against the alert. That is a fair question, and asking it is not an accusation.
Continuous monitoring is standard in neonatal intensive care and serves as the practical safeguard here. Infants on CPAP are attached to pulse oximetry and other monitors, and a loss of pressure would ordinarily trigger alarms and a bedside response. The risk described in the alert is real, but it exists inside a setting built to detect exactly this kind of failure.
An Alert Is Not Yet a Classified Recall
The early alert mechanism sits ahead of the formal recall process rather than inside it.
The FDA describes an early alert as a notification to the public about a potentially high-risk device issue while the agency is still reviewing information. No recall classification has been assigned in this case. That means the hazard has not been formally graded, and readers should not infer a severity class from the alert's existence in either direction. The agency's separate explanation of what a medical device recall is covers the subsequent classification steps.
The advantage is speed. The company letter went out on August 11, and the public notice followed roughly two weeks later, while the review continued. Under the older sequence, the public often learned of a device problem only after classification concluded.
Anyone with questions can reach the Cooper Surgical Recall Support Team at 203-895-2789 or by email at [email protected]. Clinicians and consumers can report problems through the FDA's MedWatch program.
Questions Worth Asking at the Bedside
Families of infants receiving respiratory support have a short list of questions that are appropriate at any point, independent of this alert. What equipment is my baby on, and what does it do? What alarms are set, and what happens when one sounds? Who checks the setup at shift change?
The signs that should prompt any parent to call for a nurse are the same ones staff already watch for: a change in color around the lips or face, visibly labored breathing, unusual pauses in breathing, or an unanswered monitor alarm. Parents should call rather than wait if something looks wrong, and should not adjust tubing, straps or settings themselves.
Nothing about this alert suggests families should move a baby to a different hospital or decline CPAP. Nasal CPAP prevents intubation in many newborns and is a standard, well-established therapy. The alternative to a working CPAP setup is generally a more invasive form of respiratory support, not no support at all.
The next step belongs to the FDA, which said it will update its page as significant new information becomes available, including any recall classification. Changes would appear on the agency's running list of medical device recalls and early alerts. MedicalDaily will report the classification when assigned, any expansion of affected lots, and any reported adverse events.
Key Questions Answered
What is the problem? Certain lots of CooperSurgical INCA infant and neonatal nasal CPAP sets may have a loose connection between the flexible tubing and the nasal cannula, which can leak or disconnect during use, causing a loss of pressure.
What is the health risk? Loss of CPAP pressure can reduce treatment effectiveness and lead to decreased oxygenation in a newborn until the connection is restored.
Have any infants been harmed? As of the company's August 11 letter, CooperSurgical had reported no serious injuries or deaths associated with the issue.
Is this a recall? Not a classified one yet. The FDA issued an early alert while it reviews the issue, and no recall classification has been assigned.
Do parents need to check anything at home? No. These are hospital-use devices. Identifying affected lots is the facility's responsibility.
What can a parent of a NICU infant do? Ask the charge nurse or neonatologist whether the unit uses these sets and whether inventory has been checked against the alert. Do not adjust equipment personally.
Where can problems be reported? Through the FDA's MedWatch program, or to CooperSurgical's recall support line at 203-895-2789.
